It’s no secret that traditional drug development is slow, expensive, not to mention risky, with nearly 90% of drug candidates failing to progress past clinical trials. But artificial intelligence (AI) is revolutionizing the process, delivering time and cost savings that were once unimaginable.
In recent years, AI has become integral to research and development strategies, and its influence is only accelerating. Industry experts estimate that AI adoption in the global drug discovery market will grow by 25–30% over the next five years.
And it’s already reshaping how research teams approach drug discovery across the R&D pipeline.
Researchers are using AI to:
- Analyze massive datasets in a fraction of the time it takes human researchers
- Accelerate target identification and candidate screening
- Enhance collaboration and streamline data handling
- Predict efficacy and toxicity to prioritize safer, more viable compounds earlier
- Cut development time and costs, saving up to 40% of time and 30% of expenses
- Standardize data analysis for more consistent results
- Reduce trial-and-error testing, improving efficiency.
- Repurpose existing drugs by identifying new indications
AI is enabling faster, smarter, and more cost-effective research, paving the way for breakthroughs that could transform healthcare. As AI adoption grows, the future of drug development will be shaped by how well organizations harness its power.
For many labs, that’s the conundrum: how and where to start harnessing AI’s power.
Iota: A Flexible AI Solution for R&D
Varya Virtual’s Iota is at the forefront of the AI revolution in the scientific world. Unlike other AI tools that focus on a single drug-discovery model, Iota’s power is in its flexible research infrastructure. By integrating seamlessly into research workflows, Iota accelerates target identification, streamlines candidate screening, and improves collaboration across teams. By capturing, organizing, and analyzing scientific data more efficiently, Iota reduces inefficiencies, cuts costs, and empowers organizations to achieve scientific breakthroughs.
Here’s how:
- Centralized data management: Iota centralizes data for end-to-end management, supports quality controls and security, and enables fast cross-system search.
- Organizational knowledge: By gathering and “fusing” data from various contributors, Iota builds a comprehensive knowledge base.
- Streamlined processes: Iota manages every step of the research process, from data creation and storage to cataloging, analysis, and reuse.
- Customizable modules: Iota can be tailored to meet your lab’s specific needs.
The Competitive Edge of AI in Drug Discovery
The future of early drug discovery belongs to those who harness the power and potential of AI. Companies that embrace it will have a significant advantage over those that stick to traditional methods. AI-enabled platforms like Iota are helping organizations overcome bottlenecks and discover new levels of collaboration. The result will be a better pipeline: faster insights, fewer wasted experiments, and better decisions earlier in development. AI adoption is an ongoing process, with each step bringing greater connectivity and smarter decision-making to your lab bench.
